Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A vs Oral Therapy for Diabetic Neuropathy
NCT05296759Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Feb 2021
- Primary completion
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in diabetic peripheral neuropathy (DPN), sponsored by Alexandria University. Started Feb 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT05296759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05296759.